Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China

Journal:
The Lancet
Published:
DOI:
10.1016/s0140-6736(25)01671-x
Affiliations:
6
Authors:
13
Go to article
Institutions Authors Share
National Key Laboratory of Immunity and Inflammation, China
7.000000
 0.54
Rui Therapeutics, China
2.500000
 0.19
Changhai Hospital, SMMU, China
2.000000
 0.15
Peking Union Medical College Hospital (PUMCH), China
1.000000
 0.08
Suzhou Municipal Hospital, China
0.500000
 0.04
Interested in Oncology and Carcinogenesis?